Review examines safety, effectiveness of antipsychotics in youths

02/21/2012 |

A review of 64 trials and 17 cohort studies found insufficient evidence for the comparative advantages and disadvantages of using antipsychotics among children and young adults. However, researchers reported evidence of moderate strength on the comparative effects of second-generation antipsychotics versus SGAs or SGAs versus placebo. The findings appear in the journal Pediatrics.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR